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Abstract
Background: Diaphragm dysfunction in mechanically ventilated patients is associated with poor outcome. Maximal
inspiratory pressure (MIP) can be used to evaluate inspiratory muscle function. However, it is unclear whether
respiratory weakness is independently associated with long-term mortality. The aim of this study was to determine
if low MIP is independently associated with one-year mortality.
Methods: We conducted a prospective observational cohort study in an 18-bed ICU. Adults requiring at least
24 hours of mechanical ventilation with scheduled extubation and no evidence of pre-existing muscle weakness
underwent MIP evaluation just before extubation. Patients were divided into two groups: low MIP (MIP ≤30 cmH2O)
and high MIP (MIP >30 cmH2O). Mortality was recorded for one year after extubation. For the survival analysis, the
effect of low MIP was assessed using the log-rank test. The independent effect of low MIP on post mechanical
ventilation mortality was analyzed using a multivariable Cox regression model.
Results: One hundred and twenty-four patients underwent MIP evaluation (median age 66 years (25th–75th
percentile 56–74), Simplified Acute Physiology Score (SAPS) 2 = 45 (33–57), duration of mechanical ventilation
7 days (4–10)). Fifty-four percent of patients had low MIP. One-year mortality was 31 % (95 % CI 0.21, 0.43) in the
low MIP group and 7 % (95 % CI 0.02, 0.16) in the high MIP group. After adjustment for SAPS 2 score, body mass
index and duration of mechanical ventilation, low MIP was independently associated with one-year mortality
(hazard ratio 4.41, 95 % CI 1.5, 12.9, p = 0.007). Extubation failure was also associated with low MIP (relative risk 3.0,
95 % CI 1, -9.6; p = 0.03) but tracheostomy and ICU length of stay were not.
Conclusion: Low MIP is frequent in patients on mechanical ventilation and is an independent risk factor for long-
term mortality in ICU patients requiring mechanical ventilation. MIP is easily evaluated at the patient’s bedside.
Trial Registration: This study was retrospectively registered in www.clinicaltrials.gov (NCT02363231) in February
2015.
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Background
One of the most common treatments used in intensive
care is invasive mechanical ventilation (MV), either via
an intubation tube or a tracheostomy. In 2000, an inter-
national survey revealed that 39 % of patients admitted
to intensive care undergo MV [1]. Under MV, the dia-
phragm is relaxed. This can cause a specific disorder
termed ventilator-induced diaphragmatic dysfunction
[2]. The diaphragm atrophies, changes occur in its ultra-
structure and contractility is reduced, resulting in a loss
of maximal strength [3–5].
Levine et al. showed that 18–69 hours of controlled
MV leads to more than 50 % reduction in the cross-
sectional area of type I and II diaphragm fibres [3]. This
atrophy is the result of a reduction in protein synthesis
and acceleration in protein degeneration. After only
6 hours of ventilator-induced diaphragmatic dysfunction,
the synthesis of mixed proteins is reduced by up to 30 %
and the synthesis of heavy myosin chains is reduced by
up to 65 % [6]. Hermans et al. observed negative correl-
ation between the duration of MV and transdiaphrag-
matic pressure, using magnetic stimulation of the
phrenic nerves [7]. Jaber et al. confirmed these results,
showing progressive reduction in transdiaphragmatic
pressure in ventilated patients, with a 32 % drop in
strength after 5 days of MV [4].
Many authors agree that ventilator-induced diaphrag-
matic dysfunction can increase weaning time and that it
is associated with ICU and hospital mortality [4, 8, 9]. It
is important to test for ventilator-induced diaphragmatic
dysfunction; however, there are few data in the literature
on the clinical repercussions of this condition on the
overall strength of the inspiratory muscles. De Jonghe et
al. found that maximal inspiratory pressure (MIP) below
30 cmH2O independently predicts a longer duration of
weening from MV [10]. However, more studies have
shown that MIP is not sufficiently sensitive to predict
extubation failure as it is often multifactorial [11, 12].
Moreover, most studies have only evaluated MIP as a
criterion for extubation and the samples included tend
to be small [11, 13].
The primary aim of this observational study was to
evaluate if a low MIP at the time of liberation following
MV was an independent risk factor for mortality. The
secondary aim was to evaluate outcomes after
extubation.
Method
This was a prospective observational cohort study
conducted in an 18-bed ICU between January 2014
and December 2014. Ethical approval was granted by
the French Comité de Protection des Personnes
Nord-Ouest 3. The trial is registered as NCT02363231
(www.clinicaltrials.gov).
Eligibility
Adult patients (age ≥18 years) were eligible for inclusion
if they had undergone a minimum of 24 hours of MV
and had successfully undergone a spontaneous breathing
trial. Patients were excluded in the case of a decision to
withhold life-sustaining treatment, degenerative neuro-
logical pathology with disabling muscle weakness,
chronic loss of autonomy described by the patient’s fam-
ily (a KATZ score below 6/6 [14]), agitation prior to the
evaluation (Ramsay score of 1 or Richmond Agitation-
Sedation Scale (RASS) greater than 1), or inability to
communicate.
Once the patients were no longer sedated, their state
of arousal was evaluated several times per day by the
medical and paramedical teams. When they were suffi-
ciently alert and cooperative to respond to instructions
(Ramsay score of 2), they underwent a spontaneous
breathing trial (inspiratory positive airway pressure of 7
cmH2O without expiratory positive airway pressure) for
30 to 120 minutes [15]. If the test failed, the ventilator
was returned to the initial settings and the test was re-
peated at another time. If the spontaneous breathing
trial was successful and extubation was planned, the pa-
tient was included and underwent an evaluation of MIP.
At inclusion, the following were noted: demographic
characteristics, reason for admission, comorbid factors
associated with muscle weakness or early loss of func-
tional capacity (chronic respiratory failure, obesity,
chronic cardiac failure, cancer, chronic renal failure, dia-
betes mellitus), and factors relating to the severity of the
pathology (Simplified Acute Physiology Score 2 (SAPS2),
septic shock, use of corticosteroids or curare and num-
ber of days of MV).
Mortality (of any cause) was registered at the follow
up one year after successful extubation. Following dis-
charge, patients were contacted every three months by
telephone. If the patient had died, the family was asked
to specify the date of death. If the family could not be
contacted, the mortality status of the patient was ob-
tained by checking local registries.
Evaluation of MIP
We used an electronic manometer, micro-RPM® (Eolys,
PAYS), with a unidirectional valve to measure inspira-
tory pressure. The manometer was connected to the
endotracheal intubation tube with a catheter mount.
The back-rest of the patient’s bed was inclined to 45°.
Endotracheal suction was carried out to evacuate secre-
tions. Patients were informed that MIP would be evalu-
ated at the residual volume and were instructed
accordingly. The patient was disconnected from the ven-
tilator for a minimum of 20 seconds [16]. Three mea-
surements of MIP were carried out and the best was
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used in the analysis. Finally, we defined low MIP as
lower than or equal to 30 cmH2O [10, 17].
Study outcomes
The primary outcome was death during the year follow-
ing extubation. Secondary outcomes were 30-day rate of
mortality, extubation failure, rate of tracheostomy, ICU
readmission, non-ICU readmission, correlation between
MIP and duration of mechanical ventilation prior to the
MIP measure and duration of administration of curare.
If the extubation failed, the first MIP carried out was
used in the analysis.
Statistical analysis
Patients’ characteristics were described by frequencies
and percentages for categorical parameters and as me-
dians and 25th–75th percentiles for continuous parame-
ters. Patients’ baseline characteristics were compared
between groups with low and normal MIP using the Stu-
dent t test or the Wilcoxon-Mann-Whitney test, as ap-
propriate, for continuous variables and using the Chi-
square test or Fisher exact test, as appropriate, for cat-
egorical variables. For the survival analysis, survival
curves were estimated using the Kaplan-Meier method
and the effect of low MIP was assessed using the log-
rank test. Finally, we estimated the effect of low MIP on
survival, adjusted for SAPS2, body mass index (BMI)
and duration of MV, using a multivariable Cox regres-
sion model. We chose to dichotomize the MIP variable
(using a clinical cutoff of 30 cmH2O) because the
survival analysis showed that the relationship between
MIP and mortality was not linear.
Statistical analyses were performed using R software
(Vienna, Austria, URL http://www.R-project.org/). A




We screened 856 patients and 186 patients fulfilled the
inclusion criteria. Of these, 62 had one or more exclu-
sion criteria (e.g. inability to communicate, agitation) or
could not undergo MIP evaluation (e.g. self-extubation),
as shown in Fig. 1. Therefore, 124 participants were en-
rolled in the study and underwent MIP evaluation. The
characteristics of the 124 participants are presented in
Table 1. Briefly, 41 % of the patients were women, me-
dian age was 66 years, median BMI was 27.8 Kg/m2, me-
dian SAPS2 score was 45, median duration of MV was
7 days and median MIP was 29 cmH2O.
Demographic and clinical factors according to MIP
There were 67 patients (54 %) with low MIP. The demo-
graphic characteristics, main diagnosis, severity score
and comorbid factors of the patients are presented over-
all and per MIP group in Table 1. There were no signifi-
cant differences between MIP groups at admission to
ICU.
The median number of days under MV was 8 (5–11)
in the low MIP group and 6 (4–8) in the high MIP
Fig. 1 Flow chart. MIP maximal inspiratory pressure, SBT spontaneous breathing trial
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group; the difference was not statistically significant
(p = 0.1). There was no correlation between the num-
ber of days of MV and MIP (rho = -0.17; p = 0.06) and
a weak correlation between the number of days under
curare and MIP (rho = -0.22; p = 0.01). There was no
difference between the mean MIP in patients with
sepsis and patients without sepsis (respectively, 34.6 ±
18.4 vs. 34.8 ± 20.1 cmH2O; difference between means
95 % CI -7, 6.6; p = 0.9).
Effect of MIP on mortality
The 365-day mortality was 31 % in the low MIP group
and 7 % in the high MIP group. The difference in sur-
vival curves in low and high MIP groups was statistically
significant (p < 0.001, Fig. 2). The effect of low MIP
adjusted for SAPS2 score, BMI and duration of MV
remained significant in a multivariable Cox regres-
sion model (hazard ratio (HR) 4.41, 95 % CI 1.5,
12.9; p = 0.007 (Table 2)).
The receiver operator characteristic (ROC) curve
for prediction of death by MIP is presented in Add-
itional file 1. The ROC-curve-derived optimal cutoff
was 31.5 cmH2O with sensitivity of 0.88, specificity of
0.53 and area under the curve of 0.65 (95 % CI 0.54,
0.77) (Additional file 1: Figure S1).
Clinical outcomes after extubation
Extubation failure and death in ICU were significantly
associated with low MIP (Table 3). Tracheostomy and
Table 1 Cohort characteristics
All patients Low MIP High MIP P value
n = 124 n = 67 n = 57
Female, n (%) 51 (41) 30 (45) 21 (37) 0.48
Age, median (25th–75th percentile) 66 (56–74) 69 (58–75) 64 (53–70) 0.11
Body mass index (Kg/m2), median (25th–75th percentile) 27.8 (25–32) 27.4 (24–31) 28.4 (25–33) 0.10
SAPS2 at ICU admission, median (25th–75th percentile) 45 (33–57) 46 (31–57) 45 (33–57) 0.46
Admissions to ICU within the last year, n (%) 8 (6) 3 (4) 5 (9) 0.33
Main diagnosis
Pneumonia, n (%) 33 (26) 18 (27) 15 (26) 1
Sepsis, n (%) 9 (7) 4 (6) 5 (9) 0.73
COPD/asthma exacerbation, n (%) 21 (17) 12 (18) 9 (16) 0.81
Cardiac failure, n (%) 19 (15) 11 (16) 8 (14) 0.80
Drug overdose/acute mental status change, n (%) 16 (13) 8 (12) 8 (14) 0.79
Intra-abdominal sepsis with surgery, n (%) 20 (16) 10 (15) 10 (17) 0.80
Trauma, n (%) 6 (4) 4 (6) 2 (4) 0.68
Comorbidity
Chronic pulmonary disease, n (%) 28 (22) 18 (27) 10 (18) 0.24
Obesity, n (%) 44 (35) 16 (24) 20 (35) 0.17
Chronic cardiac insufficiency, n (%) 19 (15) 11 (16) 8 (14) 0.71
Cancer, n (%) 19 (15) 13 (19) 6 (11) 0.71
Chronic kidney disease, n (%) 20 (16) 8 (12) 12 (21) 0.16
Diabetes mellitus, n (%) 30 (24) 12 (18) 18 (31) 0.07
Between admission and awakening
Septic shock, n (%) 61 (49) 33 (49) 28 (49) 0.98
ARDS, n (%) 11 (9) 3 (4) 8 (14) 0.11
Renal failure, n (%) 38 (31) 19 (28) 19 (33) 0.55
Use of cathecolamines, n (%) 64 (52) 35 (52) 29 (51) 0.87
Use of neuromuscular blockers, n (%) 76 (61) 40 (60) 36 (63) 0.85
Days on neuromuscular blockers, median (25th–75th percentile) 1 (0–3) 1 (0–3) 1(0–2) 0.70
Use of corticosteroids, n (%) 34 (27) 21 (31) 13 (23) 0.55
Ventilator use (days), median (25th–75th percentile) 7 (4–10) 8 (5–11) 6 (4–8) 0.17
SAPS2 Simplified Acute Physiology Score 2, ICU Intensive Care Unit, COPD chronic obstructive pulmonary disease, ARDS acute respiratory distress syndrome
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ICU length of stay were not associated with low MIP,
nor were ICU or non-ICU readmission.
Discussion
The results of this study showed that MIP below 30
cmH2O was independently associated with an increased
risk of mortality at one year. Moreover, more than 50 %
of the patients included had low MIP after mechanical
ventilation. Other than a weak correlation with the num-
ber of days under curare, there were no other risk fac-
tors associated with low MIP.
MIP, diaphragm dysfunction and mortality
To our knowledge, this is the largest study to evaluate
long-term mortality. A cutoff MIP value of 30 cmH2O
was used in a previous study, but the aim was to evalu-
ate weaning from MV [10]. Several studies have identi-
fied a relationship between diaphragmatic dysfunction
and mortality [8, 9]. In the present study, we used MIP,
which represents the global capacity of the inspiratory
muscles (including the diaphragm and accessory
inspiratory muscles). Currently, the majority of studies
have focused on diaphragmatic dysfunction, with similar
results. Supinski et al. observed a 49 % mortality rate in
patients with transdiaphragmatic pressure (Pdi) of 10
cmH2O (under magnetic stimulation) compared with a
rate of 7 % in patients with Pdi above 10 cmH2O [9].
Similarly, Demoule et al. observed a higher rate of mor-
tality in the ICU and other hospital wards in patients
with diaphragmatic dysfunction evaluated by Pdi during
the 24 hours following intubation [8]. However, the
evaluation of diaphragmatic dysfunction is difficult. Re-
cently, Supinski et al published an extension of their first
study, evaluating an alternative method of assessing in-
spiratory muscle capacity. They identified correlation be-
tween Pdi and MIP, and a relationship between MIP and
increased mortality, which corroborates the results of
the present study [18].
Risk factors for weakness and recovery of inspiratory
muscles
We chose to evaluate inspiratory muscle capacity just
before extubation to isolate the risk factors for mortality
relating to hospitalisation in the ICU. The main risk fac-
tors for ventilator-induced diaphragmatic dysfunction
are duration of MV [7] and sepsis [8, 9]. Surprisingly, in
the present study, we did not find a link between MIP,
sepsis and the duration of MV. The difference between
the results of the present study and that of Demoule and
Supinski may be related to the timing of the MIP. They
evaluated inspiratory muscle strength during the first
24 hours of MV, whereas we evaluated MIP at the time
of extubation, following resolution of the condition that
resulted in the need for MV. Recently Dres et al. evalu-
ated the prevalence of diaphragm weakness at the time
of liberation from MV [19]. Their univariate analysis
showed that only age at admission, and duration of MV
were associated with diaphragmatic dysfunction; how-
ever, neither of these factors were significant in the
multivariate analysis. As in our study, there was no rela-
tionship between sepsis and respiratory muscle weak-
ness, suggesting that the risk factors related to
diaphragmatic dysfunction at admission can improve
with time.
The speed of recovery of the respiratory muscles fol-
lowing weaning from MV is not known. Currently, two
studies have evaluated diaphragmatic recovery post MV
in rodents. Thomas et al. reported that a 3-hour spon-
taneous breathing trial improved ventilator-induced dia-
phragmatic dysfunction after 24 hours of MV and that
4–7 hours of spontaneous breathing trial resulted in a
total recovery of the strength and cross-sectional area of
type II fibres [20]. Bruells et al. also found a rapid im-
provement in diaphragm strength in rats 12 hours after
cessation of MV [21]. However, total recovery of
Fig. 2 Significant difference between survival curves, based on the
log-rank test (p < 0.001). Proposition: difference between survival
curves (log-rank test (p < 0.001)). MIP maximal inspiratory pressure
Table 2 Multivariable Cox regression model (at one year)
HR 95 % CI P value
Maximal inspiratory pressure ≤30 4.41 1.51, 12.90 0.007
SAPS2 1.02 1.00, 1.04 0.078
Ventilation (days) >7 1.53 0.68, 3.41 0.30
Body mass index 0.89 0.82, 0.96 0.004
HR hazard ratio, CI confidence intervals, SAPS Simplified Acute
Physiology Score
Medrinal et al. Critical Care  (2016) 20:231 Page 5 of 7
strength only occurred after 24 hours of spontaneous
breathing. No explanation was provided for the differ-
ence in these results. Despite these very encouraging re-
sults, one of the main limitations of both those studies is
that the animals evaluated were healthy. In our study,
we did not report the details of the modes of MV but we
used a department protocol to quickly shift the patients
to pressure support on cessation of neuromuscular
blocking agents. Most patients thus underwent pressure
support MV, which may have improved their inspiratory
muscle strength.
Despite these results, 54 % of the patients in the
present study had low MIP, which remains an independ-
ent risk factor for mortality. Conversely, we found that
BMI was a protective factor against mortality. This para-
dox, termed the obesity paradox, has already been dem-
onstrated in a large sample of ICU patients [22].
This study has some strong points, including its pro-
spective design and the simple method of evaluation,
which allowed us to include a large number of patients.
Moreover, this measure is easy to carry out at the pa-
tient’s bedside. This is also the first study to have evalu-
ated the clinical consequences of low MIP during the
year following discharge from ICU and hospital. How-
ever, the study has several limitations. First, it was obser-
vational and may suffer from bias inherent to this type
of design. More particularly, the small number of events
observed limited our multivariate models. The lack of
power meant that we could not fully adjust for the effect
of comorbid factors (age, sepsis, renal failure, etc.), thus,
there may be some residual confounding. However, the
most important clinical outcomes were included in the
model. Second, we do not have data on the patients’
MIP prior to admission. Third, we did not identify the
causes of mortality, and, other than the rate of readmis-
sions, we lack information on the patients’ care pathways
following discharge, including any rehabilitation they
may have undergone. Last, the use of MIP to evaluate
diaphragm dysfunction in the ICU is controversial.
Nevertheless, Caruso et al. [16] proposed a standardized
method to obtain a reproducible, maximal value of MIP
in ventilated patients. We thus followed this method in
sufficiently aroused patients (Ramsay score of 2) to en-
sure maximal participation.
Conclusion
The results of this study suggest that MIP ≤30 cmH2O
in patients in the ICU is an independent risk factor for
mortality. This measure can easily be carried out at the
patient’s bedside. The evaluation of MIP following wean-
ing from mechanical ventilation is very useful clinically.
Future studies should confirm these results and analyse
the kinetics of recovery from diaphragmatic dysfunction
in humans.
Additional file
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Table 3 Observed outcomes
Outcome after extubation Low MIP High MIP Relative risk for MIP
≤30 cmH2O (95 % CI)
P value
Extubation failure, n (%) 14 (21) 4 (7) 3 (1.1, 9.6) 0.03
Tracheostomy, n (%) 1 (1.5) 1 (1.7) 0.8 (0.05, 13.3) 1
Death within 30 days, n (%) 12 (18) 2 (3.5) 5 (1.2, 21.9) 0.04
Death in ICU, n (%) 10 (15) 1 (1.7) 8.8 (1.1, 64.1) 0.01
Death in hospital, n (%) 2 (3) 1 (1.7) 1.7 (0.1-18.2) 1
Death after hospital discharge, n (%) 9 (13) 2 (3.5) 3.7 (0.9, 17) 0.06
ICU LOS (days), median (25th–75th percentile) 10 (7–16) 9 (5–12) - 0.14
ICU readmission during the follow-up year, n (%) 6 (9) 4 (7) 1.3 (0.4, 2.7) 0.75
Non-ICU readmission during the follow-up year, n (%) 6 (9) 10 (17) 0.5 (0.2, 1.3) 0.18
MIP maximal inspiratory pressure, CI confidence intervals, ICU Intensive Care Unit, LOS length of stay
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